anticancer medication tyrosine kinase inhibitor tablets

LuciPona 45 mg is a higher strength formulation of ponatinib used in the treatment of advanced or resistant leukemia. It is prescribed when lower doses or other treatments are not sufficient. This medicine is part of specialized oncology care in the United Kingdom, United States, Australia, Singapore and Philippines. LuciPona 45 mg helps slow disease progression and manage symptoms effectively when used under expert medical guidance. Active Ingredient Ponatinib is a potent tyrosine kinase inhibitor that targets multiple signaling pathways involved in cancer growth. It is especially effective against resistant mutations. Uses of LuciPona 45 mg • Treatment of advanced leukemia • Management of resistant cancer cases • Relief from disease symptoms • Support for targeted therapy How LuciPona 45 mg Works Ponatinib blocks abnormal kinase activity in cancer cells preventing their growth and survival. This leads to reduced tumor burden and improved disease control. How to Use LuciPona 45 mg 1. Take exactly as prescribed 2. Swallow whole with water 3. Do not change dose without advice Possible Side Effects • High blood pressure • Fatigue • Nausea • Skin rash Precautions • Regular cardiovascular monitoring required • Inform doctor about liver conditions • Avoid use during pregnancy Safety Information Use only under specialist supervision. Close monitoring is essential due to potential serious side effects. Storage • Store in a cool dry place • Protect from moisture • Keep out of reach of children

LuciPona 15 mg is an anticancer medicine used in the treatment of chronic myeloid leukemia and other resistant blood cancers. It is particularly effective in patients with specific genetic mutations. This medicine is widely used across the United Kingdom, United States, Australia, Singapore and Philippines in advanced cancer care. LuciPona helps control disease progression and improves patient outcomes when taken under specialist supervision. Active Ingredient Ponatinib is a tyrosine kinase inhibitor that blocks abnormal proteins responsible for cancer cell growth. It targets specific mutations that make other treatments less effective. Uses of LuciPona 15 mg • Treatment of chronic myeloid leukemia • Management of resistant leukemia cases • Relief from cancer related symptoms • Support for targeted cancer therapy How LuciPona 15 mg Works Ponatinib inhibits tyrosine kinase enzymes involved in cancer cell signaling. This prevents abnormal cell growth and induces cancer cell death thereby controlling disease progression. How to Use LuciPona 15 mg 1. Take once daily as prescribed 2. Swallow whole with water 3. Follow medical instructions strictly Possible Side Effects • Hypertension • Fatigue • Abdominal pain • Rash Precautions • Monitor blood pressure regularly • Inform doctor about heart conditions • Avoid during pregnancy Safety Information Use under strict medical supervision. Regular monitoring is required to manage potential side effects and ensure treatment safety. Storage • Store below 30°C • Keep in original packaging • Keep away from children